Emkay

Accent Microcell Ltd.

NSE : ACCENTMICSM BSE : ISIN CODE : INE0Q5D01013Industry : Pharmaceuticals

493.55-16.00
(-3.14%)

22 Jul 2026 | 03:59

Open (Rs.)

501.50

Prev. close (Rs.)

509.55

Bid Price(Qty.)

493.55(1500)

Offer Pr.(Qty.)

0.00(0)

Volume (Rs.)

50500.00

Today's High / Low

514.00

486.00

52 Week High / Low

530.00

238.00

Company Info

Management

Mr. Vasant PatelChairman & Executive Director
Mr. Ghanshyam PatelManaging Director & CFO
Mr. Nitin PatelExecutive Director
Mr. Vinod PatelExecutive Director
Mr. Chintan BhattIndependent Director

Incorporation Year

10/04/2012

Registered Address

Registered Office : 314, Shangrilla Arcade, Shyamal Cross Road, , Anandnagar Road,Satellite,
Ahmedabad, Gujarat - 380015
Tel: Tel: 079-40042367
Fax:
Email : info@accentmicrocell.com
Website : http://www.accentmicrocell.com

Registrar Office

KFin Technologies Ltd.
Selenium Tower B, Plot No. 31-32,
Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad - 500032Tel: 040-67161500
Fax: 23420814

Listing

NSE , NSE

Financials

Owners Fund (₹ Cr.)

Net Block (₹ Cr.)

Curr. Assets (₹ Cr.)

Investments (₹ Cr.)

Note: Values are based on Consolidated Data

Shareholding Pattern

News

Please Login to view Research & Trading Ideas

Emkay Trading Ideas

Please Login to view Research & Trading Ideas

Peer Comparison

Company Name	Price ( ₹ )	Book Value ( ₹ )	EPS ( ₹ )	Market Cap. (₹ Cr.)	P/E (x)	Year End	Sales (₹ Cr.)	PAT (₹ Cr.)
+ Aarey Drugs & Pharmaceut...	75.98	53.02	1.40	215.44	54.31	202603	472.27	3.97
+ Aarti Drugs Ltd.	412.00	169.70	21.36	3,760.32	19.29	202603	2,565.31	194.92
+ Aarti Pharmalabs Ltd.	672.70	234.30	19.27	6,100.03	34.92	202603	1,819.44	174.71
+ Abbott India Ltd.	28,900.00	2,246.75	730.39	61,410.48	39.57	202603	6,929.05	1,552.02
+ Accent Microcell Ltd.	493.55	114.84	18.28	1,183.98	27.00	202603	349.03	43.86

MF Holding

No Data Available

Announcements

Date of Meeting	Purpose
12/05/2026	Audited Results, Dividend & Others
14/10/2025	Quarterly Results & Others
22/08/2025	Dividend & Others
29/05/2025	To Consider Fund Raising & Other
09/05/2025	Audited Results & Others